Heartbeam Inc BEAT

$0.39 0.00 (-1.21%)

Valuation

Market cap
22,433,000
Revenue TTM
$0
Net income TTM
$-21,020,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
545,300
Avg volume
9,140,408
Day's range
$0.39 – $0.40
Shares out
56,349,000
Stochastic %K
21%
Beta
-0.76
Analysts
Sell
Price target
$3.50

Price

Company profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnost...

Show more

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Industry
Health Information Services
Sector
Healthcare
Phone
408 899 4443
Website
https://www.heartbeam.com
Address
2118 Walsh Avenue, Suite 210, Santa Clara, United States

Latest news

Stocktwits

nick275 Oct 24, 4:45 PM
$BEAT it seems obvious the ALIGN-ACS pilot study announcement at the conference is going to be very positive. On October 5, 2026, HeartBeam announced that the FDA had granted its heart attack assessment technology Breakthrough Device Designation. This statement is in the announcement: The designation was supported by earlier proof-of-concept evidence and findings from the 134-patient ALIGN-ACS pilot study.
0 replies
ArgusDune1971 Oct 24, 4:11 PM
$BEAT The reason for my expecting a reverse split are pretty clear. If the company wanted to save the listing organically I(above a dollar for 10 days without a reverse split), they would be doing whatever they could possibly to get the stock to go up now. They clearly don't care because they have a different aim. They want to get rid of retail (the baggies) because the real money they want from institutional investors will not touch a stock that is loaded down with bagholders. If I can use Briacell as an example they will probably pull a reverse split in January to avoid any tax implications. Speaking of Briacell 1. Offering in September 2024 2. Offering in December 2024 3. Reverse split in January 2025 4. Offering in Feb 2025 5. Offering in July 2025 6. Reverse split in Aug 2025. Add to that that even before all of that happened in 2024 and 2025 whenever they had a favorable report from the FDA the stock dropped every damn time.
2 replies
TDavis12345 Oct 23, 9:52 PM
$BEAT then you own some bad, promotion-only companies🤣. Data readout heading into a BDD-designated pivotal enrolling in a few months …stock not going down if results are there. Plus, news does not move stocks up?!?!?!
2 replies
Life_Coach Oct 23, 9:11 PM
$BEAT Argus the “finfluencer” google can describe the bias.
0 replies
ArgusDune1971 Oct 23, 8:41 PM
$BEAT People need to stop with the BS. It's going to go sideways or drop. Newz does not move stocks up. I'dike to be wrong but I never have been for stocks I own 1. Catalyst released 2. Stock drops 3. Reverse split.
1 replies
Bossman123123 Oct 23, 7:41 PM
$BEAT share price prediction here after the conference? I think we can hit 1.5$ to 2$ range if there is announcement of exceptional results and a partnership
4 replies
Fredzel Oct 23, 7:01 PM
$BOLT $BEAT
0 replies
Life_Coach Oct 23, 6:48 PM
$BEAT I’ve been feeding you for 3 straight weeks. You’re bigger than a house. I’m done feeding you. Time for you to get back to work
1 replies